Terms: = Breast cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
29 results:
1. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.
Javadi M; Sazegar H; Doosti A
BMC Cancer; 2023 Nov; 23(1):1155. PubMed ID: 38012557
[TBL] [Abstract] [Full Text] [Related]
2. Conservative re-treatment of women with atypical endometrial hyperplasia and early endometrial carcinoma: We can hope, at least.
Raffone A; Raimondo D; Rovero G; Travaglino A; Lopez G; Di Maio CM; Neola D; Raspollini A; Renzulli F; Filippelli A; Casadio P; Seracchioli R; Guida M
Int J Gynaecol Obstet; 2024 May; 165(2):542-551. PubMed ID: 37772342
[TBL] [Abstract] [Full Text] [Related]
3. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese breast cancer Registry.
Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
[TBL] [Abstract] [Full Text] [Related]
5. Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making.
Lian CL; Li GQ; Zhou P; Wang J; He ZY; Wu SG
Breast; 2021 Oct; 59():117-123. PubMed ID: 34229126
[TBL] [Abstract] [Full Text] [Related]
6. Single Hormone Receptor-Positive Metaplastic breast cancer: Similar Outcome as Triple-Negative Subtype.
Mao J; Hu J; Zhang Y; Shen J; Dong F; Zhang X; Ming J; Huang T; Run X
Front Endocrinol (Lausanne); 2021; 12():628939. PubMed ID: 33972826
[TBL] [Abstract] [Full Text] [Related]
7. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.
Chen C; Xu Y; Huang X; Mao F; Shen S; Xu Y; Sun Q
Medicine (Baltimore); 2020 Aug; 99(32):e21560. PubMed ID: 32769897
[TBL] [Abstract] [Full Text] [Related]
8. Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics.
Sandsveden M; Nilsson E; Borgquist S; Rosendahl AH; Manjer J
Int J Cancer; 2020 Nov; 147(9):2424-2436. PubMed ID: 32378183
[TBL] [Abstract] [Full Text] [Related]
9. Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer.
Li Y; Su P; Wang Y; Zhang H; Liang Y; Zhang N; Song X; Li X; Li J; Yang Q
Cancer Med; 2020 Feb; 9(3):872-881. PubMed ID: 31814295
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study.
Cetintas S; Tezcan G; Tunca B; Egeli U; Gokgoz MS; Cecener G
Bosn J Basic Med Sci; 2019 May; 19(2):172-179. PubMed ID: 30242807
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.
Shen T; Gao C; Zhang K; Siegal GP; Wei S
Hum Pathol; 2017 Dec; 70():70-76. PubMed ID: 29031733
[TBL] [Abstract] [Full Text] [Related]
13. Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival.
Vos EL; Siesling S; Baaijens MHA; Verhoef C; Jager A; Voogd AC; Koppert LB
Breast Cancer Res Treat; 2017 Jul; 164(1):157-167. PubMed ID: 28389735
[TBL] [Abstract] [Full Text] [Related]
14. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract] [Full Text] [Related]
15. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
Yang Y; Lu S; Zeng W; Xie S; Xiao S
Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
[TBL] [Abstract] [Full Text] [Related]
16. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract] [Full Text] [Related]
17. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
Lambertini M; Ceppi M; Poggio F; Peccatori FA; Azim HA; Ugolini D; Pronzato P; Loibl S; Moore HC; Partridge AH; Bruzzi P; Del Mastro L
Ann Oncol; 2015 Dec; 26(12):2408-19. PubMed ID: 26347105
[TBL] [Abstract] [Full Text] [Related]
18. prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
[TBL] [Abstract] [Full Text] [Related]
19. Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors.
Vardar-Yagli N; Sener G; Saglam M; Calik-Kutukcu E; Arikan H; Inal-Ince D; Savci S; Altundag K; Kutluk T; Ozisik Y; Kaya EB
Asian Pac J Cancer Prev; 2015; 16(2):585-9. PubMed ID: 25684491
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy.
Choi JE; Kang SH; Lee SJ; Bae YK
Tumour Biol; 2014 Dec; 35(12):12255-63. PubMed ID: 25179840
[TBL] [Abstract] [Full Text] [Related]
[Next]
